BofA warns Fed risks policy mistake with early rate cuts
In a recent disclosure, Airsculpt Technologies , Inc. (NASDAQ:AIRS) reported that Adam T. Feinstein, a director and significant shareholder, purchased a total of 1,000,000 shares of common stock on June 9, 2025. The shares were acquired at a price of $4.00 each, amounting to a total investment of $4 million. The stock, which InvestingPro analysis indicates is currently trading at $5.11, has shown strong momentum with an 11% gain in the past week and appears overvalued at current levels.
The transactions were executed indirectly through various entities associated with Feinstein. Specifically, 462,957 shares were acquired by VSCP EBS Aggregator, L.P., 149,185 shares by Vesey Street Capital Partners (WA:CPAP) Healthcare Fund-A, LP, and 387,858 shares by EBS Aggregator Blocker Holdings, LLC. Following these transactions, the entities collectively hold significant positions in Airsculpt Technologies, reflecting Feinstein’s continued confidence in the company’s prospects despite current liquidity challenges, as InvestingPro data shows short-term obligations exceeding liquid assets. For comprehensive insider trading analysis and 10 additional key insights about AIRS, explore the full Pro Research Report.
In other recent news, AirSculpt Technologies reported a first-quarter revenue of $39.4 million, marking a 17.3% decline from the previous year. Despite this drop, the company exceeded earnings expectations with an EPS of -$0.02, compared to the forecasted -$0.0333. AirSculpt also announced a public offering of 3.16 million shares at $3.80 per share, aiming to raise $12 million before expenses, with Leerink Partners acting as the sole bookrunner. The company plans to use the majority of the proceeds to pay down a portion of its outstanding debt. In addition, AirSculpt confirmed the election of two Class I directors during its 2025 annual meeting and ratified Grant Thornton as its independent registered public accounting firm. Vesey Street Capital Partners, the largest shareholder, has shown interest in acquiring up to $4 million worth of shares in the offering. The company also highlighted cost-saving measures, including workforce reductions and marketing reallocations, expected to save $3 million annually. AirSculpt has set a revenue guidance of $160-170 million for 2025, with an adjusted EBITDA target of $16-18 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.